NCT02910258View on ClinicalTrials.gov

Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Myelofibrosis
Trial Locations (12)

29000

CHIC de Cornouaille, Quimper

29609

CHRU de Brest, Brest

29672

CH des pays de Morlaix, Morlaix

49000

CHU d'Angers, Angers

54511

CHU de Nancy, Vandœuvre-lès-Nancy

75475

AP-HP Hôpital Saint Louis, Paris

Unknown

Hopital du genevois, Annecy

Centre Hospitalier du Mans, Le Mans

Centre Hospitalier de Lens, Lens

Institut Paoli Calmette, Marseille

Centre Hospitalier de Nice, Nice

Centre Hospitalier de Tours, Tours

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT02910258 - Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis | Biotech Hunter | Biotech Hunter